Replies to post #222392 on Biotech Values

[DewDiligence]

Enlivex begins Nasdaq trading as ENLV:

https://www.globenewswire.com/news-release/2019/03/26/1767492/0/en/Immunotherapy-Company-Enlivex-Therapeutics-Announces-Nasdaq-Listing-Under-Symbol-ENLV-and-Closing-of-Private-Placement-of-Ordinary-Shares-Priced-at-12-25-Per-Share.html

ENLV is the result of a reverse merger with ORPN (#msg-144993741).